HRT Female (Follow up)
Test Overview
The Hormone Replacement Therapy (HRT) Female Follow-Up Panel is designed to monitor hormone levels and overall health in women undergoing hormone therapy (HT). This test ensures that estrogen, progesterone, and testosterone levels remain within an optimal range while assessing potential side effects, such as estrogen dominance, metabolic changes, or thyroid imbalances. Regular follow-up testing helps fine-tune therapy for safety and effectiveness.
Test Types
- Estrogen & Progesterone Panel: Evaluates hormonal balance for therapy adjustments.
- Testosterone Panel: Monitors androgen levels in women receiving testosterone therapy.
- Thyroid Function Panel: Ensures thyroid hormones remain stable during HRT.
- Lipid Panel & Metabolic Tests: Monitors cardiovascular and metabolic health.
- Hematocrit & Hemoglobin Panel: Checks for blood health and clotting risks.
HRT Female (Follow-Up) Test Results & Ranges
| Test Component: | Optimal Range for HRT: | Abnormal: |
|---|---|---|
| Estradiol (E2) | 50–150 pg/mL (on HRT) | >200 pg/mL may indicate estrogen dominance |
| Progesterone | 1–20 ng/mL (if supplementing) | Low may suggest inadequate dosing |
| Testosterone (Total) | 10–50 ng/dL (on therapy) | High may cause androgenic effects |
| Free Testosterone | 0.5–4.0 pg/mL | High may cause unwanted symptoms like acne or hair growth |
| Luteinizing Hormone (LH) | Suppressed on therapy | High may indicate therapy is ineffective |
| Follicle-Stimulating Hormone (FSH) | Suppressed on therapy | High suggests estrogen deficiency |
| DHEA-Sulfate (DHEA-S) | 35–250 µg/dL | Low may indicate adrenal insufficiency |
| Sex Hormone-Binding Globulin (SHBG) | 18–144 nmol/L | Low may affect free hormone levels |
| Thyroid-Stimulating Hormone (TSH) | 0.4–4.0 µIU/mL | High or low suggests thyroid dysfunction |
| Prolactin | 4–23 ng/mL | Elevated may affect hormone balance |
| Hematocrit (HCT) | 36–46% | >48% increases blood clot risk |
| Hemoglobin (HGB) | 12–16 g/dL | Elevated may suggest blood thickening |
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | Within normal lipid guidelines | Abnormal may increase cardiovascular risk |
Expected Turnaround Time
- Hormone Levels (Estradiol, Progesterone, Testosterone): 24–48 hours
- Thyroid & Metabolic Tests: 24–72 hours
- Lipid & Hematocrit Tests: 48–72 hours
Specimen Requirements
- Sample Type: Blood sample (venipuncture)
- Fasting Required? Recommended for lipid and metabolic tests
- Container: Serum separator tube (SST) or EDTA tube
Collection Instructions
- Schedule blood draw based on therapy timing:
- Estradiol & Progesterone: Test at the midpoint of dosing cycle.
- Testosterone (if applicable): Test before the next dose for trough levels.
- Fast for 8–12 hours if undergoing lipid or metabolic testing.
- Avoid strenuous exercise for 24 hours before testing.
- Provide a full medication/supplement list, especially HRT medications.
- Storage: Keep refrigerated if not processed immediately.
Test Details
- Clinical Use: Monitors hormone levels to optimize therapy. Ensures estrogen and progesterone balance for symptom management. Tracks testosterone therapy effects to prevent excess androgenic symptoms. Evaluates thyroid function to detect any secondary imbalances.
- Limitations: Hormone levels fluctuate; testing at the right time is crucial. Medications and lifestyle factors can influence results.
The HRT Female Follow-Up Test ensures safe, effective, and personalized hormone therapy management by tracking key health markers and optimizing treatment.